glp-1 dementia news Adults whose type 2 diabetes was treated with receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective In New Dementia Trials, Ozempic's

Oral semaglutide showed cardiovascular safety profile, with significant reduced risk of death from cardiovascular events

Start your weight-loss journey for the last time.

They should only be used under the supervision of a qualified healthcare provider

The overall safety profile appears favorable, with serious adverse events being relatively rare and consistent with the broader GLP-1 receptor agonist class

Gather Supplies: Before using Trulicity injection, make sure you have all the necessary supplies including a Trulicity pre-filled pen, a alcohol prep pad, and a sharps container

This may help you feel fuller sooner, reduce hunger, and lower overall calorie intake